Product Information
GNP NAPROXEN SODIUM 220 MG CAP is a generic product labeled by AmerisourceBergen, priced at $0.1494 per EA under NDC 46122078064. Its NADAC has been published 93 times since Dec 25, 2024.
FDA first approved this application on Feb 17, 2006.
Strength
220 mg/1
Manufacturer
AmerisourceBergenNDC
46122078064
Classification
Generic
Dosage Form
CAPSULE, LIQUID FILLED
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
NAPROXEN SODIUMApproval Type
New Drug (NDA)
FDA Application
NDA021920FDA Approved
2/17/2006
On Market Since
4/11/2024
Pharmacological Classes
Price Statistics
The NADAC for GNP NAPROXEN SODIUM 220 MG CAP has been published 93 times since Dec 25, 2024, and over the history we have for it it has declined 3.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1494 per EA |
|---|---|
| All-time high | $0.1555 (Jan 15, 2025) |
| All-time low | $0.1331 (Jul 23, 2025) |
| 52-week high | $0.1513 |
| 52-week low | $0.1422 |
| Median price | $0.1442 |
| Average price | $0.1440 |
| Largest weekly change | +4.5% (Aug 20, 2025) |
| Weeks tracked | 93 |
| Tracking since | Dec 25, 2024 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Naproxen Sodium market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
AmerisourceBergen manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Naproxen Sodium market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Nonsteroidal Anti-inflammatory Drug class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of GNP NAPROXEN SODIUM 220 MG CAP?
The current National Average Drug Acquisition Cost (NADAC) for GNP NAPROXEN SODIUM 220 MG CAP, manufactured by AmerisourceBergen, is $0.1494 per EA (NDC 46122078064), effective Sep 30, 2026.
How has the price of GNP NAPROXEN SODIUM 220 MG CAP changed over time?
Over the history we have for it, the NADAC for GNP NAPROXEN SODIUM 220 MG CAP has declined 3.9%. It has been tracked across 93 weekly CMS publications since Dec 25, 2024.
What are the highest and lowest recorded NADAC prices for GNP NAPROXEN SODIUM 220 MG CAP?
Since Dec 25, 2024, the NADAC for GNP NAPROXEN SODIUM 220 MG CAP has ranged from a low of $0.1331 (Jul 23, 2025) to a high of $0.1555 (Jan 15, 2025), with a median of $0.1442 per EA.
Are there cheaper alternatives to GNP NAPROXEN SODIUM 220 MG CAP?
No other NADAC-published product currently shares the active ingredient and strength of GNP NAPROXEN SODIUM 220 MG CAP in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures GNP NAPROXEN SODIUM 220 MG CAP?
GNP NAPROXEN SODIUM 220 MG CAP (NDC 46122078064) is labeled by AmerisourceBergen, and CMS classifies it as a generic product.